As demonstrated, compared with the control group, the concentrations of NEBL, EPB41L2, and FGD4 were significantly decreased in the AD group (Figure 6A–C), while the concentration of MARCKS protein showed a slight elevation in AD serum, without statistical difference (Figure 6D, p = 0.27). This evidence concerns the gene FGD4 and Alzheimer disease.